Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphomaJennifer L. Crombie, Anupama Kalsekar, Monika Jun et al.|Leukemia & lymphoma/Leukemia and lymphoma|2024Cited by 6
Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosisAnindit Chhibber, David C. Young, M. Sakil Syeed et al.|Journal of Cystic Fibrosis|2024Cited by 4